New Key Statistics Module, Z-Score and F-Score
NAS:TLIS Key Ratios
Market Cap $ M | 7.08 |
Enterprise Value $ M | -33.98 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.15 |
Price/Sales | 24.48 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -28.02 |
Beneish M-Score | -7.36 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 18.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.61 |
EV-to-EBITDA | 0.62 |
PEG | -- |
Shares Outstanding M | 1.82 |
Net Margin (%) | -17,008.67 |
Operating Margin % | -18,374.00 |
Pre-tax Margin (%) | -17,008.67 |
Quick Ratio | 7.76 |
Current Ratio | 7.76 |
ROA % (ttm) | -53.13 |
ROE % (ttm) | -72.45 |
ROIC % (ttm) | -268.84 |
Dividend Yield % | -- |
Altman Z-Score | -12.03 |
TLIS Number of Guru Trades
TLIS Volume of Guru Trades
Gurus Latest Trades with NAS:TLIS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TLIS is held by these investors
Total 1
Talis Biomedical Corp Insider Transactions
No Available Data
News about NAS:TLIS
Total 0- 1